Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey NASDAQ2020, I know Nasrat mentioned Elite has 8 to 10% of Vyvanse market then with considering generic market is 68% ish then we are talking about $240 million+ per year ( or $60M per quarter) from Vyvanse sell. What do you think?
Nasrat wants a lot of things for ELTP and for himself but everything IMO takes time. This is one of those you can't rush because Nasrat set a time for himself. He sure can work towards it but I think this will take time and $2.5 can happen. All IMO of course...
that's the point you could have bought at and made the most money. buying at .20 or .30 or .40 would have done well too. the highest i bought at was. 30 and sold at. 70. that's why im not here crying like some.
let's be honest. you're upset with yourself for not selling some. it's easier to hold thru a drop when you've already done well and when you have other big gainers.
The whole phuckin point is you're purposely choosing the lowest PPS since Nasrat became CEO to make yourself (and him) feel good about yourselves.
It's the same pathetic example Nasrat used in the most recent CC (.03-.05 to .75)
Well guess what, you could just as easily choose the highest PPS which is what I did...
I like a little sarcasm..but I'm the king..ha
Yaaaa my wall street friends think it’s the best possible way to get the best price. Put your self up for a bidding war. Your right as always
An old broker friend of mine who I've talked with about Elite over the many years was stunned into silence on the phone when I told him about the Slickster's M&A talk....then, after he recovered, he said..What!!!...he talked about that on a CC?
Ahaha..even if the talk about looking for an investment bank could somehow not be BS....a CEO should not disclose that..I don't know how many more ways I can dream up to say the same thing...I'm about out of ammo.
Did Elite hire an actual legit "big boy" M&A firm?
Because we all know Nasrat is a cheap bastard.
Wouldn't be surprised if he hired his high school buddies down the street at the local In-N-Out Burger.
As I previously posted..just let the numbers do the talking...he's caused enough damage with that big mouth.
I don't think people realize how phuckin DUMB Nasrat is.
This is the same misfit who had to redo the ENTIRE vote at the shareholder meeting several years ago because he phucked up the first one.
Shareholders LITERALLY had to submit their entire vote again about 6 months later. Such an embarrassment.
ALERT: The Mikah Conference Call is on August 15. This is our last chance to RAISE HELL about The Mikah Scam.
I can just imagine what a legitimate brokerage firm would think when the little CEO tells them that he wants to sell Elite along with his little private pharmaceutical company that he owns 100% of and runs on the side, together!!!!!!!
I expect they will walk away thinking, UN-ETHIC-AL,
Amazing post.
Time for Nasrat to announce his resignation?
Nasrat has managed to squash the share price during and following the calls!!! If things go as projected, we have 3 or 4 more calls before we all hit the cashier's window!!! Can we blame Nasrat for this continued precipitous fall or are there other factors at work? My money is on our CEO and his ineffective communication skills!! OK, what do we do at this point in time!!! Yes, his ego may not be as large as the one in D.C, but it is plenty big to impact his decisions on holding on to the Mike. My recommendation is we write or get the word to him to stay off the conference calls for the remainder of the CC's.
......and how willing they are to even consider a very small company with a very big 1000 million OS
Which is why we need to uplist first.
As I stated recently, selling Elite on the OTC is financial SUICIDE.
We're going to get pennies on the dollar (assuming shareholders are stupid enough to vote YES)
**Hypothetical** Lets say by end of the year, or spring 2026 the stock price is $1. Let's also assume they've done a valuation and arrived at $3 and a larger pharma also makes an offer for this price. **Hypothetical**
Do "optics" play into anything for the acquirer? Or is it strictly numbers-based and what is agreed upon by both companies as a fair price?
Does the bigger company care or have to worry about "justifying" in any way when the articles say that they paid 200% over the target's current stock price?
There will be no surprises in the next report as this will be Elite's first 10-Q with Vyvanse sales.
Last report was the annual report and everything was combined for the entire year.
Also, like everyone knows, you compare quarter OVER quarter, not quarter TO quarter.
I was thinking he should have brought up the delay of Lisdex skewing the numbers at this CC to avoid a “surprise” disappointment at the next.
Nice...
Put NH's mouth in his pocket for a few q's
Are you including the following in your valuation?
✅️ ART tech
✅️ Pharma tariffs premium
✅️ $18,365,748 deferred income tax asset
✅️ No debt (Cash on hand - current debt)
✅️ Israel partnership (Adderall IR + Adderall XR (upcoming) + Vyvanse (upcoming)
✅️ Purchase of Mikah Adderalls
✅️ Generic OxyContin
I think the company is worth 1.35 a share. Do you think goodwill would jack that up to 2.50, close to 100%?
So in 12 freaking years you LOST money because of inflation:
2014: .97
2026: 1.35
i agree with 1.35 and that's a big accomplishment considering it was .03.
Golden Goose only brought in $7M last quarter.
$19M : Standard revenue
$6M: Delayed revenue
$7M: Vyvanse
TOTAL: $32M
Golden Goose = $ 14M/ quarter = 8-10% of $4.3 Billion market
Schedule:
August 14: FY2026 Q1 10-Q filed
August 15: Mikah Conference Call
2 companies for the price of one. 1+1
Costco deal!!!
Just being curious …… if you place a $2.00 per share price on Elite if the company were to be acquired next week in an all cash transaction, what would be your price if nasrat would sell all of Mikah’s interests to Elite “AGAIN” and truly shut Mikah down ?????
I can just imagine what a legitimate brokerage firm would think when the little CEO tells them that he wants to sell Elite along with his little private pharmaceutical company that he owns 100% of and runs on the side, together!!!!!!!
I expect they will walk away thinking, UN-ETHIC-AL,
IB_🤴
The acquiring price will depend on many factors. How much will Elite complement the acquiring company, perhaps a sales and dostributor wants to vertically integrate with mfg, or an international company looking for a US presence, etc. Too many options to consider how much a company is willing to pay above market value.
He also ignores potential BE and/or submissions to possibly be revealed, the possibility of Oxy, the emergence into Israel that holds potential. The value of purchasing a well oiled money making company. He simply takes the current sales and adds 1 more quarter, possibly 2 to get to his 150 mil per year and ignores the rest. $2.00. JMO
i agree with 1.35 and that's a big accomplishment considering it was .03. we all would have been elated with 1+ a year ago.
I just wonder how they’ll figure out a price when the 27 billion drug is so speculative at the buyout stage.
I’m guessing they’ll wait for when it’s more certain and extend the buyout timeline.
Their paying for the revenues generated 5 years out per N2K.
I get it, he is the guy who got us here. He is also the one who will have the biggest smile when all is said and done. Again, we are close to something- the key is what is that something. Is it 7.00 or nothing or something considerably below that number. Like many here, in this case a penny is not a penny, it is thousands of dollars!!! We are close to the finish line and .10 .20 cents or on and on will mean very significant dollars to the folks that have held tough over the years!!! Crunch time!!! Pull out all stops to take this gem to the price that it deserves, Time will tell, as I am sure 99.9% of the folks here are rooting and praying that you have it right. We all know the one that is the most probable dissenter!!
Enjoy the day!!
But nasrat wants to start selling in a few months.
I think the company is worth 1.35 a share. Do you think goodwill would jack that up to 2.50, close to 100%?
A year in pharma industry is not that long. With $27b ANDA when approved and launched into the market, we can see 500m revenue and $2.5b is not a lot for that kind of company with sequestox tech on the shelf for now. IMO.
Usually when you acquire a company you overpay. That's what you call "goodwill" in accounting and is actually recorded as an intangible asset.
I just don’t see it. Not with the outstanding shares and how competitive the market is. Who will pay 2.5 billion plus for a company making say at most 150 million a year even with the shiny new facility? And there is still a long way to go with that 27 billion anda.
Nasrat is a strategic thinker
I like his honesty with us. No bs.
My expectations on the buyout price is $2.5 or more. We will be trading at $1.25 before the end of 2025 IMO.$$$Eltp$$$
I agree about the price and I’m glad we got the hype buyout stage out the way. I think buyout guesses will be more realistic and conservative now. I think I’m dropping mine to 1.35.
THX rdfdr1, And Naltrexone is no longer in shortage
https://dps.fda.gov/drugshortages/activeingredient/naltrexone-hydrochloride-tablet
i am sure this has bee posted before, but it bares reposting:https://www.nasdaq.com/articles/elite-pharmaceuticals-stock-dips-despite-record-fy25-revenue-jump
Understood!!! Just throwing out an idea that will never stick but to me makes a lot of sense. Put NH's mouth in his pocket for a few q's,
Over and out, on to the next!!
Happy 4th!!
Historically it has been like that since 2012. The day traders do it every Cc. Independently of what Nasrat says.
Appreciate your help, I need all I can get. At the end of the day, the quarter after quarter hits gets old!!! With all the excellent news it was a major disappointment in my view. Apparently, many others spoke with their pocketbooks. Nasrat has been the benefactor as we have as shareholders of some good hops in the past couple of years. I applaud him but I still maintain we all have strengths and opportunity areas.
At the end of the day, I have both eyes open that we hit the lottery with this one!!!! For many years i had to use eye drops whenever checking my eltp account. Not so much anymore.
Much Thanks Nasrat!!
Off to the 4th of July barbecue.
Happy 4th to my fellow lottery winners!!!
Share prices for companies trading on the otcqb is a less relevant factor in a buyout. Generally much less liquidity than on an exchange, more risk of manipulation you all whine about and the QB has little to no participation from funds/institutions etc that makes share price even less important
Fundamental valuations are what counts.
Do you think a potential acquirer will raise their offer 35% because ELTP has a higher share price?
it wasnt that long ago that Nasrat subtly told us Lisdex was all but guaranteed to pass. after that info was processed, the share prices start rising nicely. Nasrat also was forthright about preparing to sell the company. that's why traders pushed it into the .80s. there are a lot of shortsighted comments since the CC. Nasrat has been very good at telling us what we want to hear in subtle ways. it appears most of you havent realized what he's telling us.
let me help you. Nasrat basically just advised us to keep buying in his usual way. i don't forsee $3 but i think 1.50 to 2.50 is pretty likely.
I kick myself to keep thinking things will be different this time! Other than the very rare occasion ,Nasrat has managed to squash the share price during and following the calls!
Same! Happy Independence Day to all longs. 🇺🇸 🦅
Likely N/A for the bottom feeders/parasites overseas anyway.
Lots of opinions!!! You have mine!!!
GLTA
I pity your life
Followers
|
1149
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
431362
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators Dr Speculator Ninja mrwrn2010 NASDAQ2020 namtae |
Senior Moderator: NASDAQ2020
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 68 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 421.7 M | On Market | 16 | Elite, Dexcel |
Adderall XR | 865 M | On Market | 10 | Elite |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 47 M | On Market | 5 | Elite |
Dopamine Agonist | 12 M | Filed with FDA - Dec 22, 2022 | ---------- | ---------- |
Methotrexate | 63 M | On Market | 8 | Elite |
Percocet | 317 M | On Market | 14 | Elite |
Norco | 300 M | On Market | 12 | Elite |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - Aug 17, 2023 | 4 | ---------- |
Vyvanse | 4.3 B | On Market | 13 | Elite |
Concerta | 1.16 B | BE Studies | 8 | ---------- |
Undisclosed ANDA | 27 B | Positive BE Study | 1 | ----------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 | 84,043,929 | +48.42% | (4,314,659) | -121.47% |
+ | + | + | + | |
Chart |
Board Manager: NASDAQ2020 Last Updated: JULY 02, 2025 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |